RP103
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RP103, covering 2014-10-28 to 2018-05-11. Get the full timeline:
Most recent: Clinical Trial Update: A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease [Phase 2]